Scolr Pharma, Inc. (SCLR) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Scolr Pharma, Inc. Company Snapshot

Business Description:

Scolr Pharma, Inc. operates in the Diagnostic substances sector. SCOLR Pharma, Inc. is a specialty pharmaceutical company that combines formulation experience and knowledge with its Controlled Delivery Technology (CDT) platforms to develop and commercialize prescription, over-the-counter (OTC), and nutritional products. The Company has developed multiple private label extended release nutritional products incorporating its formulation technology for commercialization in the United States and Canada. Its lead drug product candidate is a 12 hour extended release formulation of ibuprofen, an analgesic used for the treatment of pain, fever and inflammation. In our complete report available for purchase the company is compared to: Cyclacel Pharmaceuticals, Inc., Bio-Bridge Science, Inc. and Oncovista Innovative Therapies, Incorporation.

Scolr Pharma, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .08
(Figures in U.S. Dollars)

1 Week	6.7%	13 Weeks	0.0%

4 Weeks	-20.0%	52 Weeks	-66.7%

Scolr Pharma, Inc. Key Data:

Ticker:	SCLR	Country:	UNITED STATES

Exchanges:	OTC	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	618,000 (Year Ending Jan 2011).	Employees:	6

Currency:	U.S. Dollars	Market Cap:	3,985,286

Fiscal Yr Ends:	December	Shares Outstanding:	49,816,073

Share Type:	Common	Closely Held Shares:	1,428,346

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.